Cho Ray Hospital has anti-rejection drugs for kidney transplant recipients
Today, anti-rejection drugs for kidney transplant recipients are available at Cho Ray Hospital. These drugs, if bought outside, cost several million dong/box.
Doctor Pham Thanh Viet, Head of General Planning Department, Cho Ray Hospital, said that the hospital now has enough anti-rejection drugs for kidney transplant patients participating in Health Insurance.
Talking to VietNamNet, Doctor Pham Thanh Viet said that as soon as there was a shortage of health insurance drugs for kidney transplant recipients, the hospital determined this was an emergency. The Board of Directors has convened relevant councils and departments to find a solution to get the drug as soon as possible.
Specifically, Cho Ray Hospital has over-purchased 20% with one drug, the remaining 4 types are organized for procurement in the form of contractor appointment. Then, conduct public bidding according to regulations. Today, the medicine is fully available at the Hospital.
“Up to now, we have solved the shortage of anti-rejection drugs. From now on, there will be enough medicine for the patient,” Viet said.
In addition, for those who had to buy drugs from outside at high cost, Cho Ray Hospital has sent a document to Social Insurance to ensure the legitimate interests of patients. At the same time, the Social Work Department supports the cost of buying drugs for poor and near-poor patients while the hospital runs out of drugs.
Doctor Pham Thanh Viet also said that the procurement of drugs in public health facilities must follow the bidding forms in accordance with regulations. Occasionally, there are objective cases where the drug does not win the bid. For example, there are no bidders, bids fail due to dossiers or overpriced…
At that time, the hospital could not supply drugs as prescribed and patients with health insurance had to buy them outside. Before 2018, Social Insurance will pay this cost directly to the patient. After that, change to Cho Ray Hospital to pay the patient and Social Insurance to pay back to the hospital.
“However, from 2018 to now, the insurance agency has not done this anymore. The parties (Hospital and Insurance) are all following the regulations, but they are also very sorry for the patient because this is their legitimate right,” said Doctor Viet.
Previously, many press agencies have reported the shortage of transplant rejection drugs for patients participating in Health Insurance at Cho Ray Hospital. Some patients who come to the follow-up appointment have to buy this medicine from outside at a very high cost, up to millions of dong.
Anti-rejection drugs are drugs that must be taken for life with organ transplant recipients. The above drugs belong to the group of drugs for national price negotiation, depending on the centralized drug bidding.
Regarding the shortage of drugs at Cho Ray Hospital, the Ministry of Health confirmed that this was an undesirable event. The Ministry of Health has directed the National Center for Centralized Drug Procurement to expeditiously deploy the national centralized bidding for drugs and negotiate prices.
As soon as the results are available, the Ministry of Health (National Centralized Drug Procurement Center) will announce the winning results and the Framework Agreement for medical facilities to deploy and implement.
Linh Giao
at Blogtuan.info – Source: vietnamnet.vn – Read the original article here